🇺🇸 FDA
Patent

US 8987420

High affinity human antibodies to human angiopoietin-2

granted A61KA61K2039/505A61K31/513

Quick answer

US patent 8987420 (High affinity human antibodies to human angiopoietin-2) held by REGENERON PHARMACEUTICALS, INC. expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2039/505, A61K31/513, A61K38/1866, A61K38/1891